In a small trial with 32 patients with bowel cancer the immunotherapy drug pembrolizumab was given nine weeks prior to surgery (instead of the chemotherapy and surgery). 59 percent of the patients had no sign of cancer and did not need surgery, in 41 percent of the cases the cancer was removed during surgery. All patients were cancer free after the treatment. Bigger studies are needed.
related: #immunotherapy #bowel_cancer #pembrolizumab
Contact: info(@)neat-news(dot)com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
Note that photos are usually stock photos, mostly taken from
Wikipedia, which we can use royalty-free either since they are in
the public domain or available under an open licence such as
a share alike licence.
The page is maintained in Germany and for any legal matters the
laws of Germany apply.
Any warranty or liability is excluded in the widest legally
possible sense.
© neat-news.com 2016-2025.